NCT07576582 Peloid Therapy in Temporomandibular Joint Dysfunction
| NCT ID | NCT07576582 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Uşak University |
| Condition | Temporomandibular Disorders (TMDs) |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-04-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective, single-group clinical study will evaluate whether local peloid therapy improves pain and jaw function in adults with temporomandibular joint dysfunction. Participants will receive peloid therapy applied to the temporomandibular joint region and masticatory muscles for 20 minutes per session, 5 days per week, for 2 weeks. Pain and functional outcomes will be measured at baseline and at the end of treatment using validated clinical scales, including the Jaw Functional Limitation Scale-8, visual analog scale pain scores, Fonseca index, maximum mouth opening, and secondary otalgia assessment.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 65 years * Diagnosis of temporomandibular joint dysfunction based on DC/TMD criteria * Presence of TMJ-related pain for at least 4 weeks * Baseline pain intensity ≥3 on a 0-10 visual analog scale * Ability to provide written informed consent Exclusion Criteria: * History of temporomandibular joint trauma, tumor, active infection, or acute inflammation * Previous temporomandibular joint surgery * Presence of systemic inflammatory rheumatologic disease * Pregnancy * Open wound, active dermatitis, or skin condition preventing peloid application at the treatment site * Injection therapy (e.g., botulinum toxin) or regular physical therapy for TMJ within the past 3 months * Any clinical or behavioral condition that may interfere with study compliance
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07576582 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Temporomandibular Disorders (TMDs). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07576582 currently recruiting?
Yes, NCT07576582 is actively recruiting participants. Contact the research team at fkbakkal@gmail.com for enrollment information.
Where is the NCT07576582 trial being conducted?
This trial is being conducted at Uşak, Turkey (Türkiye).
Who is sponsoring the NCT07576582 clinical trial?
NCT07576582 is sponsored by Uşak University. The trial plans to enroll 40 participants.